Skip to main content

Table 1 Baseline characteristics of CAD patients and controls

From: Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study

Variable

CAD patients ( n= 151)

Controls ( n= 34)

P value

Age (years)

57 ± 11

56 ± 12

0.6

Body-mass index (kg/m2)

27.5 ± 3.8

27.3 ± 3.7

0.8

Current smokers, n (%)

41 (27%)

7 (21%)

0.5

Left ventricular ejection fraction (%)

69 ± 7

70 ± 6

0.4

Hypertension, n (%)

121 (80%)

25 (74%)

0.4

Systolic blood pressure (mm Hg)

130 ± 10

129 ± 12

0.6

Diastolic blood pressure (mm Hg)

79 ± 8

80 ± 9

0.5

Estimated GFR (mL/min per 1.73 m2)

71 ± 10

75 ± 13

0.05

Low-density lipoproteins cholesterol (mmol/L)

2.8 ± 0.7

2.6 ± 0.7

0.3

High-density lipoproteins cholesterol (mmol/L)

0.9 ± 0.3

1.0 ± 0.4

0.02

Triglycerides (mmol/L)

1.5 ± 0.8

1.4 ± 0.7

0.5

High-sensitivity C-reactive protein (mg/L)

1.8 (1.1–3.8)

1.6 (1.0–3.3)

0.07

Glucose (mmol/L)

5.8 ± 0.8

5.6 ± 0.7

0.25

HOMA-IR index

3.2 (2.4–4.9)

2.9 (2.3–4.7)

0.2

ADMA (μmol/L)

0.51 ± 0.10

0.46 ± 0.09

0.01

L-arginine (μmol/L)

70 ± 18

71 ± 17

0.7

  1. Data are shown as mean ± SD, median (interquartile range) or n (%).
  2. Abbreviations: ADMA asymmetric dimethylarginine, CAD coronary artery disease, GFR glomerular filtration rate, HOMA-IR homeostasis model assessment for insulin resistance.